Yellow Webinars
Il lancio degli YELLOW WEBINARS aggiunge un’importante attività al ruolo multitasking la Fondazione Italiana Fegato. Poiché la pandemia del 2020 ha cambiato sostanzialmente le nostre vite, abbiamo deciso di trasformare i tradizionali Yellow Seminars in presenza in Yellow Webinars consentendo alla FIF di diffondere meglio e ampiamente il messaggio scientifico . La qualità dei relatori e la rilevanza degli argomenti sono autoesplicativi.
Gli Yellow Webinars si svolgono sulla nostra piattaforma Zoom
_____________
The launch of the YELLOW WEBINARS adds an important activity to the multitasking role of the Italian Liver Foundation. Since the 2020 pandemic has substantially changed our lives, we have decided to transform the traditional Yellow Seminars in presence into Yellow Webinars allowing the FIF to better and widely disseminate the scientific message. The quality of the speakers and the relevance of the topics are self-explanatory.
The Yellow Webinars are hosted on our Zoom platform
Zoom ID : 454 870 8300
pw: liver
Download – YW Calendar 2025
Watch the past Yellow Webinars on
FIF Youtube Channel
https://www.youtube.com/@fondazioneitalianafegato
January 13, 2025
2.00 p.m. CET
Metabolic alterations in MASLD: lipids but also glucose
Amalia Gastaldelli, PhD
Research Director of Cardiometabolic Risk Unit
Institute of Clinical Physiology, CNR Pisa Italy
Professor of Medicine-adjunct, UT Medical Center San Antonio TX, USA
Professor-Adjunct Scuola Superiore Sant’Anna Pisa
February 10, 2025
2.00 p.m. CET
Advancing Pediatric Cancer Research
Group Leader, Princess Maxima Center for Pediatric Oncology
Research Chair, Maxima Comprehensive Childhood Cancer Center Liver Tumor Group
Utrecht, The Netherlands
March 3, 2025
2.00 p.m. CET
Generative Artificial Intelligence in Hepatology
Mauro Giuffrè
Specialist in Digestive Diseases
Postdoctoral Fellow at Yale School of Medicine
Department of Internal Medicine
Section of Digestive Diseases
March 31, 2025
2.00 p.m. CET
Cholestatic liver disease – PBC and PSC
Andreas Teufel
Professor of Hepatology, Division of Hepatology,
Department of Internal Medicine II, Medical Faculty Mannheim,
Heidelberg University, Germany
April 14, 2025
2.00 p.m. CEST
Hepatic Mitochondrial SAB level modulates Mitochondrial Stress, Steatohepatitis, Metabolic Syndrome, and Hepatic Fibrosis
Sanda Win, MD, PhD,
Assistant Professor
Department of Medicine
Division of Gastroenterological and Liver Diseases
Keck School of Medicine
University of Southern California
May 5, 2025
2.00 p.m. CEST
Estimating presence of liver disease due to SLD
and risk of future cirrhosis in the general population
Hannes Hagström, MD, PhD
Professor, Karolinska Institutet
Consultant hepatologist,
Karolinska University Hospital,
Stockholm, Sweden
May 19, 2025
2.00 p.m. CEST
Metabolic dysfunction-associated steatotic liver disease (MASLD), cardiovascular and chronic kidney disease risk, and new treatments
Chris D Byrne, MB BCh PhD
Professor Endocrinology & Metabolism
University of Southampton &
University Hospital Southampton, UK
June 16, 2025
2.00 p.m. CEST
News about neonatal jaundice diagnosis and management
Prof. Daniele DE LUCA (MD,PhD)
Full Professor of Pediatrics (Neonatology)
Division Chief, Pediatrics, Transportation and Neonatal Critical Care
Immediate Past President – European Society for Pediatric and Neonatal Intensive Care (ESPNIC)
Editor – European Journal of Pediatrics
AP-HP Université Paris Saclay “A. Béclère” Medical center
& INSERM Research Unit U999 “Physiopathology and Therapeutic Innovation”
June 31, 2025
2.00 p.m. CEST
Metabolic changes in hepatic steatosis and their effect on drug toxicity
Principal Investigator – Liver Metabolism Lab,
Department of Molecular Biology, Ariel University, Israel
Archive:
Watch the past Yellow Webinars on FIF Youtube Channel
https://www.youtube.com/@fondazioneitalianafegato
Yellow Webinar Series 2024 – January-July
Calendar 2024 Jan- July_update
Yellow Webinar Series 2024 – September-December
Calendar 2024 SEPT-DEC
Yellow Webinar Series 2023
Calendar 2023 full
September 8, 2025
2.00 p.m. CET
Effect of endocrine disrupting chemicals (EDCs)
in the progression of MASLD
PhD Principal Investigator, Group Obesity, Diabetes and Comorbidities, Centro de Investigacion Principe Felipe CIPF Valencia Biomedical Research Foundation, Spain
September 22, 2025
2.00 p.m. CET
Extrahepatic cancer associated with MASLD –
understanding the pathogenesis, burden of disease and treatment approaches
B.Sc (Hons), MB ChB, MRCP(UK), MD
Specialist Trainee in Hepatology and Research Fellow at the University of Dundee
NHS Tayside and University of Dundee,
Division of Clinical and Molecular Medicine, Ninewells Hospital and Medical School, Dundee, United Kingdom.
Member of global NASH council
October 13, 2025
2.00 p.m. CET
Steatotic liver promotes Metastatic Tumor Environment
MD, PhD, AGAF, FAASLD
Professor of Medicine
Director, Basic Liver Research
Karsh Division of Gastroenterology and Hepatology, Department of Medicine
Cedars-Sinai Medical Center ,Los Angeles, CA, USA
October 20, 2025
2.00 p.m. CET
Mechanisms controlling liver regeneration in human chronic liver diseases
Einstein Professor for Stem Cells in Regenerative Therapies
Berlin Institute of Health (BIH)
BIH Center for Regenerative Therapies (BCRT)
Cranach Haus Charité – Universitätsmedizin Berlin, Germany
October 27, 2025
2.00 p.m. CET
Liver Cell plasticity and tissue repair
Group Leader, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
November 10, 2025
2.00 p.m. CET
Screening for MASLD-related advanced fibrosis :
finding the needle in the haystack
Department of medicine and surgery, University of Milano Bicocca; Department of Medicine and Rehabilitation, Policlinico di Monza, Monza, Italy
November 17, 2025
2.00 p.m. CET
Non-invasive evaluation of liver diseases and portal hypertension
Associate Professor of Gastroenterology,
Gastroenterology and Hepatology Unit, Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialities, PROMISE, University of Palermo
Former Secretary of the Italian Association for the Study of the Liver (AISF)
November 24, 2025
2.00 p.m. CET
In vivo genetic engineering of hepatocytes to treat inherited metabolic diseases
Group Leader, the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) and Assistant Professor, Vita-Salute San Raffaele University, Milan, Italy
December 1, 2025
2.00 p.m. CET
Transcriptional regulation of liver functions in health and in MASLD
Director INRAE Toxalim, Université de Toulouse, France
December 15, 2025
2.00 p.m. CET
Multimodal decoding of human liver regeneration and repair
PhD, FRCP, FAASLD, FMedSci
Professor of Tissue Repair and Regeneration
Wellcome Trust Senior Research Fellow in Clinical Science
Co-Director, Wellcome Trust Edinburgh Clinical Academic Track (ECAT) Programme
Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, UK